Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK (vol 13, pg 632, 2019)

Bromley Susan E.; Matthews Anthony; Smeeth Liam; Stanway Susannah; Bhaskaran Krishnan

首页> 外文期刊>Journal of cancer survivorship: research and practice >Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK (vol 13, pg 632, 2019)

【24h】

Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK (vol 13, pg 632, 2019)

机译：用芳香酶抑制剂治疗的绝经后乳腺癌患者痴呆风险与Tamoxifen治疗：使用来自英国的初级保健数据的群组研究（Vol 13，PG 632,2019）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of cancer survivorship: research and practice 》 |2019年第6期| 共1页
作者
Bromley Susan E.; Matthews Anthony; Smeeth Liam; Stanway Susannah; Bhaskaran Krishnan;
展开▼
作者单位

London Sch Hyg &

Trop Med Dept Noncommunicable Dis Epidemiol London England;

London Sch Hyg &

Trop Med Dept Noncommunicable Dis Epidemiol London England;

London Sch Hyg &

Trop Med Dept Noncommunicable Dis Epidemiol London England;

Royal Marsden NHS Fdn Trust Sutton Surrey England;

London Sch Hyg &

Trop Med Dept Noncommunicable Dis Epidemiol London England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK (vol 13, pg 632, 2019) [J] . Bromley Susan E., Matthews Anthony, Smeeth Liam, Journal of cancer survivorship: research and practice . 2019 ,第6期

机译：用芳香酶抑制剂治疗的绝经后乳腺癌患者痴呆风险与Tamoxifen治疗：使用来自英国的初级保健数据的群组研究（Vol 13，PG 632,2019）
2. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK [J] . Bromley Susan E., Matthews Anthony, Smeeth Liam, Journal of cancer survivorship: research and practice . 2019 ,第4期

机译：用芳香酶抑制剂对糖糖酶抑制剂治疗的绝经后乳腺癌患者痴呆症风险与Tamoxifen：使用英国初级护理数据的群组研究
3. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study [J] . Hong Namki, Yoon Han Gyul, Seo Da Hea, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2017 ,第期

机译：新出现脂肪肝和脂质变化的不同模式与患有早期乳腺癌的绝经后妇女的三莫莫毒素与芳香酶抑制剂的变化：倾向分数匹配的队列研究
4. Aromatase Inhibitors in Prevention - Data from the ATAC (Arimidex, Tamoxifen Alone or in Combination) Trial and the Design of IBIS-II (the Second International Breast Cancer Intervention Study) [C] . Jack Cuzick International Society of Cancer Chemoprevention . 2003

机译：预防芳族酶抑制剂 - 来自ATAC（ARIMIDEX，Tamoxifen单独或组合或组合的数据）的数据和IBIS-II的设计（第二次国际乳腺癌干预研究）
5. Symptoms experienced by post-menopausal breast cancer survivors on Aromatase Inhibitors: A secondary analysis of baseline data. [D] . Cao, May N. 2013

机译：绝经后乳腺癌幸存者在芳香酶抑制剂上的症状：基线数据的二次分析。
6. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK [O] . Susan E. Bromley, Anthony Matthews, Liam Smeeth, -1

机译：用芳香化酶抑制剂和他莫昔芬治疗的绝经后乳腺癌幸存者患痴呆症的风险：一项使用英国初级保健数据的队列研究
7. Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK [O] . Susan E. Bromley, Anthony Matthews, Liam Smeeth, 2019

机译：用芳香酶抑制剂治疗的绝经后乳腺癌患者的痴呆症风险与Tamoxifen治疗：使用来自英国的初级保健数据的队列研究

Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK (vol 13, pg 632, 2019)

著录项

相似文献

相关主题

期刊订阅